User:Barbara (WVS)/sandbox/ht templates

References[edit | edit source]

Jump up^ Oxford Dictionary: Definition of amitriptyline (British & World English) ^ Jump up to:a b c d e f g h i j k l m "Amitriptyline Hydrochloride". The American Society of Health-System Pharmacists. Retrieved Sep 25, 2014. Jump up^ Leucht, C; Huhn, M; Leucht, S (December 2012). "Amitriptyline versus placebo for major depressive disorder.". The Cochrane Database of Systematic Reviews. 12: CD009138. . doi:10.1002/14651858.CD009138.pub2. ^ Jump up to:a b Moore, RA; Derry, S; Aldington, D; Cole, P; Wiffen, PJ (6 July 2015). "Amitriptyline for neuropathic pain in adults.". The Cochrane database of systematic reviews. 7: CD008242. . doi:10.1002/14651858.CD008242.pub3. Jump up^ "Prescribing medicines in pregnancy database". Australian Government. 3 March 2014. Retrieved 22 April2014. Jump up^ "Amitriptyline Levels and Effects while Breastfeeding". drugs.com. Sep 8, 2014. Retrieved 25 September 2014. Jump up^ Sneader, Walter (2005). Drug Discovery a History.Chichester: John Wiley & Sons. p. 414. ISBN 9780470015520. Jump up^ Fangmann P, Assion HJ, Juckel G, González CA, López-Muñoz F (February 2008). "Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics". Journal of Clinical Psychopharmacology. 28 (1): 1–4. . doi:10.1097/jcp.0b013e3181627b60. Jump up^ "WHO Model List of Essential Medicines (19th List)"(PDF). World Health Organization. April 2015. Retrieved 8 December 2016. Jump up^ "Amitriptyline". International Drug Price Indicator Guide. Retrieved 2 December 2015. ^ Jump up to:a b "AMITRIPTYLINE HYDROCHLORIDE tablet, film coated [Dispensing Solutions, Inc.]". DailyMed. Dispensing Solutions, Inc. September 2013. Retrieved 1 December 2013. ^ Jump up to:a b c d e f g Rossi, S, ed. (2013). Australian Medicines Handbook (2013 ed.). Adelaide: The Australian Medicines Handbook Unit Trust. ISBN 978-0-9805790-9-3. ^ Jump up to:a b c Joint Formulary Committee (2013). British National Formulary (BNF) (65th ed.). London, UK: Pharmaceutical Press. ISBN 978-0-85711-084-8. Jump up^ Barbui C, Hotopf M (February 2001). "Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials". The British Journal of Psychiatry. 178 (2): 129–144. . doi:10.1192/bjp.178.2.129. Jump up^ Anderson IM (April 2000). "Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efﬁcacy and tolerability". Journal of Affective Disorders. 58(1): 19–36. . doi:10.1016/S0165-0327(99)00092-0. Jump up^ https://www.ncbi.nlm.nih.gov/pubmed/8736630 Jump up^ Kennea, NL; Evans, JHC (June 2000). "Drug Treatment of Nocturnal Enuresis" (PDF). Paediatric and Perinatal Drug Therapy. Informa Healthcare. 4 (1): 12–18. doi:10.1185/1463009001527679.[permanent dead link] ^ Jump up to:a b Viera AJ, Hoag S, Shaughnessy J (2002). "Management of irritable bowel syndrome" (PDF). Am Fam Physician. 66(10): 1867–74. . Jump up^ Parkinson's disease. Merck Sharp & Dohme Corp. August 2007. Retrieved on 2013-12-22. Jump up^ PJ Millea; JJ Brodie (2002-09-01). "Tension-Type Headache". Am Fam Physician. 66 (5): 797–805. ^ Jump up to:a b c "Levate (amitriptyline), dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. Retrieved 1 December 2013. Jump up^ Flament MF, Bissada H, Spettigue W (March 2012). "Evidence-based pharmacotherapy of eating disorders". International Journal of Neuropsychopharmacology. 15 (2): 189–207. . doi:10.1017/S1461145711000381. Jump up^ Mendelson WB, Roth T, Cassella J, Roehrs T, Walsh JK, Woods JH, Buysse DJ, Meyer RE (February 2004). "The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium". Sleep Med Rev. 8 (1): 7–17. . doi:10.1016/s1087-0792(03)00042-x. Jump up^ Sim Y-J, Kim J-M, Kwon S, Choe B-H (2009). "Clinical experience with amitriptyline for management of children with cyclic vomiting syndrome". Korean Journal of Pediatrics. 52(5): 538–43. doi:10.3345/kjp.2009.52.5.538. Jump up^ Boles RG, Lovett-Barr MR, Preston A, Li BU, Adams K (2010). "Treatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective study". BMC Neurol. 10: 10. PMC 2825193 . . doi:10.1186/1471-2377-10-10. Jump up^ Chung, KF (2008). "Currently available cough suppressants for chronic cough.". Lung. 186 Suppl 1: S82–7. . doi:10.1007/s00408-007-9030-1. Jump up^ Wald, Arnold (2006). "Functional biliary type pain syndrome". In Pasricha, Pankaj Jay; Willis, William D.; Gebhart, G. F. Chronic Abdominal and Visceral Pain. London: Informa Healthcare. pp. 453–62. ISBN 978-0-8493-2897-8. Jump up^ http://www.drugs.com/monograph/amitriptyline-hydrochloride.html Jump up^ http://gi.org/guideline/management-of-gastroparesis ^ Jump up to:a b "Amitriptyline Tablets BP 50mg - Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Actavis UK Ltd. 24 March 2013. Retrieved 1 December 2013. ^ Jump up to:a b Wesley R. Zemrak, Pharm.D.; George A. Kenna, Ph.D., B.S.Pharm (2008). "Association of Antipsychotic and Antidepressant Drugs With Q-T interval Prolongation". WebMD LLC. Retrieved January 14, 2017. ^ Jump up to:a b c d e f g h i j k l m n o p q "Endep Amitriptyline hydrochloride" (PDF). TGA eBusiness Services. Alphapharm Pty Limited. 10 December 2012. Retrieved 1 December 2013. Jump up^ Roth, BL; Driscol, J. "PDSP Ki Database" (HTML). Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Retrieved 14 August 2017. ^ Jump up to:a b c d e Tatsumi M, Groshan K, Blakely RD, Richelson E (1997). "Pharmacological profile of antidepressants and related compounds at human monoamine transporters". Eur. J. Pharmacol. 340 (2-3): 249–58. . ^ Jump up to:a b c d e Owens MJ, Morgan WN, Plott SJ, Nemeroff CB (1997). "Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites". J. Pharmacol. Exp. Ther. 283 (3): 1305–22. . ^ Jump up to:a b c d e f g Cusack B, Nelson A, Richelson E (1994). "Binding of antidepressants to human brain receptors: focus on newer generation compounds". Psychopharmacology (Berl.). 114 (4): 559–65. . ^ Jump up to:a b Peroutka SJ (1988). "Antimigraine drug interactions with serotonin receptor subtypes in human brain". Ann. Neurol. 23(5): 500–4. . doi:10.1002/ana.410230512. Jump up^ Peroutka SJ (1986). "Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex". J. Neurochem. 47 (2): 529–40. . Jump up^ Roth BL, Kroeze WK (2006). "Screening the receptorome yields validated molecular targets for drug discovery". Curr. Pharm. Des. 12 (14): 1785–95. . Jump up^ Pälvimäki EP, Roth BL, Majasuo H, Laakso A, Kuoppamäki M, Syvälahti E, Hietala J (1996). "Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor". Psychopharmacology (Berl.). 126 (3): 234–40. . Jump up^ Kohen R, Metcalf MA, Khan N, Druck T, Huebner K, Lachowicz JE, Meltzer HY, Sibley DR, Roth BL, Hamblin MW (1996). "Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor". J. Neurochem. 66 (1): 47–56. . Jump up^ Hirst WD, Abrahamsen B, Blaney FE, Calver AR, Aloj L, Price GW, Medhurst AD (2003). "Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling". Mol. Pharmacol. 64 (6): 1295–308. . doi:10.1124/mol.64.6.1295. Jump up^ Monsma FJ, Shen Y, Ward RP, Hamblin MW, Sibley DR (1993). "Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs". Mol. Pharmacol. 43 (3): 320–7. . Jump up^ Shen Y, Monsma FJ, Metcalf MA, Jose PA, Hamblin MW, Sibley DR (1993). "Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype". J. Biol. Chem. 268 (24): 18200–4. . Jump up^ Bylund DB, Snyder SH (1976). "Beta adrenergic receptor binding in membrane preparations from mammalian brain". Mol. Pharmacol. 12 (4): 568–80. . Jump up^ Sánchez C, Hyttel J (1999). "Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding". Cell. Mol. Neurobiol. 19 (4): 467–89. . ^ Jump up to:a b c d e f von Coburg Y, Kottke T, Weizel L, Ligneau X, Stark H (2009). "Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics". Bioorg. Med. Chem. Lett. 19 (2): 538–42. . doi:10.1016/j.bmcl.2008.09.012. Jump up^ Ghoneim OM, Legere JA, Golbraikh A, Tropsha A, Booth RG (2006). "Novel ligands for the human histamine H1 receptor: synthesis, pharmacology, and comparative molecular field analysis studies of 2-dimethylamino-5-(6)-phenyl-1,2,3,4-tetrahydronaphthalenes". Bioorg. Med. Chem. 14 (19): 6640–58. . doi:10.1016/j.bmc.2006.05.077. Jump up^ Leslie Iversen (29 June 2013). Biochemical Studies of CNS Receptors. Springer Science & Business Media. pp. 404–. ISBN 978-1-4684-4361-5. Jump up^ Ross J. Baldessarini (1985). Chemotherapy in Psychiatry: Principles and Practice. Harvard University Press. pp. 156–. ISBN 978-0-674-11383-1. ^ Jump up to:a b Nguyen T, Shapiro DA, George SR, Setola V, Lee DK, Cheng R, Rauser L, Lee SP, Lynch KR, Roth BL, O'Dowd BF (2001). "Discovery of a novel member of the histamine receptor family". Mol. Pharmacol. 59 (3): 427–33. . ^ Jump up to:a b c d e Stanton T, Bolden-Watson C, Cusack B, Richelson E (1993). "Antagonism of the five cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells by antidepressants and antihistaminics". Biochem. Pharmacol. 45 (11): 2352–4. . ^ Jump up to:a b c Bymaster FP, Nelson DL, DeLapp NW, Falcone JF, Eckols K, Truex LL, Foreman MM, Lucaites VL, Calligaro DO (1999). "Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro". Schizophr. Res. 37 (1): 107–22. . Jump up^ Weber E, Sonders M, Quarum M, McLean S, Pou S, Keana JF (1986). "1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs". Proc. Natl. Acad. Sci. U.S.A. 83(22): 8784–8. PMC 387016 . . Jump up^ Teschemacher AG, Seward EP, Hancox JC, Witchel HJ (1999). "Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline". Br. J. Pharmacol. 128 (2): 479–85. PMC 1571643 . . doi:10.1038/sj.bjp.0702800. Jump up^ "Potency of antidepressants to block noradrenaline reuptake". CNS Forum. Retrieved 2013-02-16. Jump up^ Albert Ellis; Gwynn Pennant Ellis (1 January 1987). Progress in Medicinal Chemistry. Elsevier. p. 56. ISBN 978-0-444-80876-9. Retrieved 27 November 2011. Jump up^ D. Sriram; P. Yogeeswari (1 September 2010). Medicinal Chemistry. Pearson Education India. p. 299. ISBN 978-81-317-3144-4. Retrieved 27 November 2011. Jump up^ Alan F. Schatzberg; Charles B. (2006). Essentials of clinical psychopharmacology. American Psychiatric Pub. p. 7. ISBN 978-1-58562-243-6. Jump up^ Rauser L, Savage JE, Meltzer HY, Roth BL (October 2001). "Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor". J. Pharmacol. Exp. Ther. 299 (1): 83–9. . Jump up^ Werling LL, Keller A, Frank JG, Nuwayhid SJ (October 2007). "A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder". Exp. Neurol. 207 (2): 248–57. . doi:10.1016/j.expneurol.2007.06.013. Jump up^ Sills MA, Loo PS (July 1989). "Tricyclic antidepressants and dextromethorphan bind with higher affinity to the phencyclidine receptor in the absence of magnesium and L-glutamate". Mol. Pharmacol. 36 (1): 160–5. . Jump up^ Pancrazio JJ, Kamatchi GL, Roscoe AK, Lynch C (January 1998). "Inhibition of neuronal Na+ channels by antidepressant drugs". J. Pharmacol. Exp. Ther. 284 (1): 208–14. . Jump up^ Punke MA, Friederich P (May 2007). "Amitriptyline is a potent blocker of human Kv1.1 and Kv7.2/7.3 channels". Anesthesia and Analgesia. 104 (5): 1256–1264. . doi:10.1213/01.ane.0000260310.63117.a2. ^ Jump up to:a b Jang SW, Liu X, Chan CB, Weinshenker D, Hall RA, Xiao G, Ye K (June 2009). "Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity". Chem. Biol. 16 (6): 644–56. PMC 2844702 . . doi:10.1016/j.chembiol.2009.05.010. Jump up^ "Pharmaceutical Information - AMITRIPTYLINE". RxMed. Retrieved 2013-02-16. Jump up^ Kornhuber J, Muehlbacher M, Trapp S, Pechmann S, Friedl A, Reichel M, Mühle C, Terfloth L, Groemer TW, Spitzer GM, Liedl KR, Gulbins E, Tripal P (2011). Riezman H, ed. "Identification of novel functional inhibitors of acid sphingomyelinase". PLoS ONE. 6 (8): e23852. PMC 3166082 . . doi:10.1371/journal.pone.0023852. Jump up^ The Pharmaceutical Codex. 1994. Principles and practice of pharmaceutics, 12th edn. Pharmaceutical press Jump up^ Hansch C, Leo A, Hoekman D. 1995. Exploring QSAR.Hydrophobic, electronic and steric constants. Washington, DC: American Chemical Society. Jump up^ Yalkowsky SH, Dannenfelser RM; The AQUASOL dATAbASE of Aqueous Solubility. Ver 5. Tucson, AZ: Univ AZ, College of Pharmacy (1992) ^ Jump up to:a b Amitriptyline. Martindale: The Complete Drug Reference. London, UK: Pharmaceutical Press. 30 January 2013. Retrieved 2 December 2013. Jump up^ "Pamelor, Aventyl (nortriptyline) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. Retrieved 2 December 2013. Jump up^ Rudorfer MV, Potter WZ (1999). "Metabolism of tricyclic antidepressants". Cell Mol Neurobiol. 19 (3): 373–409. . ^ Jump up to:a b Stingl JC, Brockmoller J, Viviani R (2013). "Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function". Mol Psychiatry. 18 (3): 273–87. . doi:10.1038/mp.2012.42. ^ Jump up to:a b Kirchheiner J, Seeringer A (2007). "Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes". Biochim Biophys Acta. 1770 (3): 489–94. . doi:10.1016/j.bbagen.2006.09.019. ^ Jump up to:a b c d Hicks JK, Swen JJ, Thorn CF, Sangkuhl K, Kharasch ED, Ellingrod VL, Skaar TC, Muller DJ, Gaedigk A, Stingl JC (2013). "Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants". Clinical Pharmacology & Therapeutics. 93 (5): 402–8. PMC 3689226 . . doi:10.1038/clpt.2013.2. Jump up^ Swen JJ, Nijenhuis M, de Boer A, Grandia L, Maitland-van der Zee AH, Mulder H, Rongen GA, van Schaik RH, Schalekamp T, Touw DJ, van der Weide J, Wilffert B, Deneer VH, Guchelaar HJ (2011). "Pharmacogenetics: from bench to byte--an update of guidelines". Clinical Pharmacology & Therapeutics. 89 (5): 662–73. . doi:10.1038/clpt.2011.34. ^ Jump up to:a b Michael S Ritsner (15 February 2013). Polypharmacy in Psychiatry Practice, Volume I: Multiple Medication Use Strategies. Springer Science & Business Media. pp. 270–271. ISBN 978-94-007-5805-6. Jump up^ Neal R. Cutler; John J. Sramek; Prem K. Narang (20 September 1994). Pharmacodynamics and Drug Development: Perspectives in Clinical Pharmacology. John Wiley & Sons. pp. 160–. ISBN 978-0-471-95052-3. Jump up^ Pavel Anzenbacher; Ulrich M. Zanger (23 February 2012). Metabolism of Drugs and Other Xenobiotics. John Wiley & Sons. pp. 302–. ISBN 978-3-527-64632-6. Jump up^ Patricia K. Anthony (2002). Pharmacology Secrets. Elsevier Health Sciences. pp. 39–. ISBN 1-56053-470-2. Jump up^ Philip Cowen; Paul Harrison; Tom Burns (9 August 2012). Shorter Oxford Textbook of Psychiatry. OUP Oxford. pp. 532–. ISBN 978-0-19-162675-3. ^ Jump up to:a b c d J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 889–. ISBN 978-1-4757-2085-3. ^ Jump up to:a b c d e f Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 48–. ISBN 978-3-88763-075-1. Jump up^ I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 15–. ISBN 978-94-011-4439-1. ^ Jump up to:a b c https://www.drugs.com/international/amitriptyline.html Jump up^ "Amitriptyline". Drugs.com. Retrieved 2 December 2013.

Further reading[edit | edit source]

PubChem Substance Summary: Amitriptyline National Center for Biotechnology Information. TREPILINE-10 TABLETS; TREPILINE-25 TABLETS South African Electronic Package Inserts. 12 May 1978. Revised February 2004. SAROTEN RETARD 25 mg Capsules; SAROTEN RETARD 50 mg Capsules South African Electronic Package Inserts. December 1987. Updated May 2000. AMITRIP Amitriptyline hydrochloride 10 mg, 25 mg and 50 mg Capsules Medsafe NZ Physician Data Sheet. November 2004. Endep Consumer Medicine Information, Australia. December 2005. MedlinePlus Drug Information: Amitriptyline. US National Institutes of Health. January 2008.

[show]

Medical uses

[show]

Pharmacodynamics

[show]

v t e

Tricyclics

Categories (++): Alpha blockers (−) (±) Amines (−) (±) Dibenzocycloheptenes (−) (±) Dopamine antagonists (−) (±) H1 receptor antagonists (−) (±) Muscarinic antagonists (−) (±) Serotonin antagonists (−) (±) Serotonin-norepinephrine reuptake inhibitors (−) (±) Sigma agonists (−) (±) Sodium channel blockers (−) (±) Tricyclic antidepressants (−) (±) TrkB agonists (−) (±) World Health Organization essential medicines (−) (±) (+)

Hidden categories: All articles with dead external links Articles with dead external links from June 2017 Articles with permanently dead external links CS1 maint: Multiple names: authors list Template:drugs.com link with non-standard subpage ECHA InfoCard ID from Wikidata Drugboxes which contain changes to watched fields Pages using div col with small parameter RTT (−) (±)

Navigation menu

Barbara (WVS) 18 12 Talk Sandbox Preferences Beta Watchlist Contributions Log out

Article Talk

Read Edit Edit source View history Watch

More

Page

TW

Search

Main page Contents Featured content Current events Random article Donate to Wikipedia Wikipedia store

Interaction

Help About Wikipedia Community portal Recent changes Contact page

Tools

What leaves here What links here Related changes Upload file RTRC Special pages Permanent link Page information Wikidata item Cite this page Expand citations Highlight duplicate links DYK check

Print/export

Create a book Download as PDF Printable version

In other projects

Wikimedia Commons

Languages

Simple English Kreyòl ayisyen Arabic Azerbaijani Chinese Dutch Estonian Finnish French German Hungarian Italian Japanese Korean Malayalam Norwegian Norwegian Nynorsk Odia Persian Polish Portuguese Russian Serbian Serbo-Croatian Spanish Swedish Vietnamese

Edit links

This page was last edited on 21 August 2017, at 15:35. Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.